|
|
||||||||
Departments of Radiology Imabari Ehime Hospital, Ehime University School of Medicine, Ehime, Japan
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Correspondence: For correspondences and reprints contact: Teruhito Mochizuki, MD, Radiology, Ehime Imabari Hospital, 4-5-5 Ishii-cho, Imabari-city, Ehime 794, Japan.
ABSTRACT
This paper evaluates the clinical usefulness of 201Tl to image hepatocellular carcinoma (HCC), using 201Tl, 99mTc-phytate (colloid) and a three-headed SPECT camera. Methods: The tumor-to-nontumor ratios (T/N) of 201Tl for different categories of HCC were generated. Tumors were emphasized by image subtraction (201Tl-99mTc-colloid). Thirty-three lesions in 16 patients (18 studies) with HCC were evaluated. There were 19 untreated nodular, five untreated diffuse, five local recurrent and four necrotic lesions after interventional therapy. Results: The mean T/N were as follows: untreated nodular 1.54 ± 0.31 (mean ± s.d.), untreated diffuse 1.28 ± 0.26, local recurrence 1.50 ± 0.29 and necrosis 0.22 ± 0.06. All the tumors (except necrotic areas) were enhanced by the image subtraction. Conclusion: Thallium-201 is useful for liver tumor imaging but 99mTc-phytate (colloid) is essential to discriminate 201Tl tumor uptake from normal liver accumulation. Image subtraction (201Tl/99mTc-colloid) is helpful in detecting HCC.
Key Words: thallium-201 technetium-99m-phytate SPECT subtraction images hepatocellular carcinoma
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |